摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1H-pyrrolizine | 251-59-2

中文名称
——
中文别名
——
英文名称
1H-pyrrolizine
英文别名
——
1H-pyrrolizine化学式
CAS
251-59-2
化学式
C7H7N
mdl
——
分子量
105.14
InChiKey
ODMMNALOCMNQJZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    4.9
  • 氢给体数:
    0
  • 氢受体数:
    0

文献信息

  • [EN] BICYCLOAMINE-SUBSTITUTED-N-BENZENESULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS<br/>[FR] COMPOSÉS DE BENZÈNESULFONAMIDE À SUBSTITUTION BICYCLOAMINE AYANT UNE ACTIVITÉ SÉLECTIVE DANS LES CANAUX SODIQUES SENSIBLES À LA TENSION
    申请人:MERCK SHARP & DOHME
    公开号:WO2015077905A1
    公开(公告)日:2015-06-04
    Disclosed are compounds of Formula (A-a), or a salt thereof, Where "B1" and "R1" through "R5" are as defined herein, which compounds have properties for blocking Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula (A-a) or their salts, and methods of treating neuropathic pain disorders using the same.
    公开的是式(A-a)的化合物或其盐,其中“B1”和“R1”至“R5”如本文所定义,这些化合物具有阻断外周和交感神经元中发现的Nav 1.7离子通道的特性。还描述了包含式(A-a)的化合物或其盐的药物配方,以及使用它们治疗神经病性疼痛障碍的方法。
  • Method for Producing Aromatic and Heteroaromatic Carboxylic Acids, Carboxylic Acid Esters and Carboxylic Acid Amides
    申请人:Challand Nina
    公开号:US20110172456A1
    公开(公告)日:2011-07-14
    Process for the preparation of aromatic and heteroaromatic carboxylic acids, carboxylic acid esters and carboxamides by the reaction of aromatic or heteroaromatic halides R—X n , in which n=integer from 1 to 6, R=substituted or unsubstituted and aromatic or heteroaromatic radical and X=chlorine, bromine or iodine atom, with carbon monoxide and water, ammonia, alcohols or amines in the presence of bases and zero-valent or divalent palladium compounds and bidentate diphosphanes or complexes of zero-valent or divalent palladium with bidentate diphosphanes, in which use is made of bidentate diphosphanes (R 1 —)(R 2 —)P—Y—P(—R 3 )(—R 4 ) in which R 1 to R 4 =unsubstituted aryl radicals or aryl radicals substituted with at least one radical exhibiting a positive resonance effect or a positive inductive effect, or unsubstituted or substituted cycloalkyl radicals, and Y=hydrocarbon group with a total of 2 to 20 carbon atoms, in which at least one of the carbon atoms carries only one or no hydrogen atom as substituent; except for the reaction of 4-bromo-3-difluoromethyl-1-methylpyrazole with 2-(3,4,5-trifluorophenyl)aniline and carbon monoxide to give N-[2-(3,4,5-trifluorophenyl)phenyl]-3-difluoromethyl-1-methylpyrazole-4-carboxamide.
    用芳香或杂芳卤代烃R—Xn(其中n=1到6的整数,R=取代或未取代的芳香或杂芳基团,X=氯、溴或碘原子)与一氧化碳和水、氨、醇或胺在碱存在下,以及零价或二价钯化合物和双膦或零价或二价钯与双膦的配合物反应,制备芳香和杂芳羧酸、羧酸酯和羧酰胺的方法的过程,其中使用双膦(R1—)(R2—)P—Y—P(—R3)(—R4),其中R1到R4=未取代芳基基团或带有至少一个正共振效应或正归纳效应的基团的取代芳基基团,或未取代或取代的环烷基基团,Y=含有2到20个碳原子的碳氢基团,其中至少一个碳原子只携带一个或没有氢原子作为取代基;但不包括4-溴-3-二氟甲基-1-甲基吡唑与2-(3,4,5-三氟苯基)苯胺和一氧化碳反应形成N-[2-(3,4,5-三氟苯基)苯基]-3-二氟甲基-1-甲基吡唑-4-羧酰胺。
  • Compounds
    申请人:Wadman Sjoerd Nicolaas
    公开号:US20110294723A1
    公开(公告)日:2011-12-01
    The present disclosure relates to compounds of formula (II): pharmaceutical compositions comprising same and use of the compounds and compositions for the treatment of microbial infection, particularly Methicillin-resistant Staphylococcus aureus (MRSA) infection.
    本公开涉及化合物的公式(II):包括相同的药物组合物以及用于治疗微生物感染,特别是耐甲氧西林金黄色葡萄球菌(MRSA)感染的化合物和组合物的用途。
  • Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses
    申请人:L'OREAL
    公开号:US20040231067A1
    公开(公告)日:2004-11-25
    The subject of the present application is a dyeing composition for dyeing keratinous fibres, in particular human keratinous fibres such as hair, comprising, in an appropriate dyeing medium, at least one cationic tertiary para-phenylenediamine containing a pyrrolidine ring, and at least one particular heterocyclic coupler. The subject of the invention is also the dyeing method using this composition.
    本申请的主题是一种染色组合物,用于染色角蛋白纤维,特别是人类角蛋白纤维,如头发,包括在适当的染料介质中,至少包含一种含有吡咯烷环的阳离子第三对苯二胺,以及至少一种特定的杂环偶合剂。本发明的主题还包括使用该组合物的染色方法。
  • CATIONIC COMPOUND, DYE COMPOUND AND METHOD OF USING THE SAME, AND OPTICAL INFORMATION RECORDING MEDIUM
    申请人:Nii Kazumi
    公开号:US20090130367A1
    公开(公告)日:2009-05-21
    The present invention relates to a cationic compound denoted by the general formula (I). In general formula (I), Ar 1 and Ar 2 each independently denote an optionally substituted aryl group or aromatic heterocyclic group, L 1 denotes a single bond or a divalent linkage group, with at least one from among Ar 1 , Ar 2 and L 1 comprising one or more onium cations; R 3 and R 4 each independently denote a substituent and may form a ring with a benzene ring substituted; m3 and m4 each independently denote an integer ranging from 0 to 4, and plural R 3 s and R 4 s may be identical or different from each other when m3 and m4 are an integer ranging from 2 to 4.
    本发明涉及一种由一般式(I)表示的阳离子化合物。在一般式(I)中,Ar1和Ar2各自独立地表示可选取代的芳基或芳香杂环基团,L1表示单键或二价连接基团,其中至少有一个来自于Ar1、Ar2和L1中的一个或多个离子上阳离子;R3和R4各自表示取代基团,并且可以与苯环取代形成环;m3和m4各自独立地表示从0到4的整数,当m3和m4为从2到4的整数时,复数的R3和R4可能相同也可能不同。
查看更多

同类化合物

野百合碱 螺[环氧乙烷-2,1'-吡咯里嗪] 脱氢野百合碱 矮陀陀酰胺碱 灰毛束草碱 毛束草碱 暗黄猪屎豆碱 去氢毛果天芥菜碱 去氢天芥菜碱 去氢倒千里光裂碱 去氢倒千里光裂碱 去氢倒千里光碱 克拉沙霉素B 克拉沙霉素A N-甲基-N-[(2R,3R,3aS,4S,6alphaS)-2,3,3a,6alpha-四氢-2,4-甲桥-4H-呋喃并[3,2-b]吡咯-3-基]-乙酰胺 N-(3-羟基-2,4-二甲基苯基)乙酰胺 8-氧杂-5-氮杂三环[5.1.1.01,5]壬-2,6-二烯 8-氧杂-2-氮杂三环[5.2.1.02,6]癸-1(9),3,5-三烯 7-羟基-6,7-二氢-5H-吡咯里嗪-1-甲醛 7-(羟基甲基)-3H-吡咯里嗪-3-酮 7-(甲氧基羰基)-6,7-二氢-5H-吡咯啉-1-羧酸 3H-吡咯里嗪-3,5(2H)-二硫酮 3-氨基-N-[2,5-二氢-5-羰基-1-(2,4,5-三氯苯基)-1H-吡唑-4-基]苯酰胺 3-氧代吡咯里嗪-2-羧酸乙酯 3-氧代-3H-吡咯里嗪-2-甲酰氯 3-氧代-2,3-二氢-1H-吡咯里嗪-5-羧酸 3-氧代-2,3,5,7a-四氢-1H-吡咯里嗪-7-甲醛 3-氧-3氢-吡咯嗪-2-甲酸 3-(2,6-二乙酰基-3,7-二甲基-5H-吡咯里嗪-1-基)丙酸 2H,3H-氧杂环丁烷并[2,3-a]吡咯里嗪 2-(6-乙基-2,3-二氢-1H-吡咯里嗪-1-基)苯胺 2,5-二(叔-壬基二硫代)-1,3,4-噻二唑 2,3-二氢-7-甲基-1H-吡咯里嗪-1-酮 2,3-二氢-7-(羟基甲基)-1H-吡咯里嗪-1-酮 2,3-二氢-1H-吡咯里嗪-7-羧酸 2,3-二氢-1H-吡咯里嗪-7-甲醇 2,3-二氢-1H-吡咯里嗪-7-甲腈 2,3-二氢-1H-吡咯里嗪-1-甲腈 2,3-二氢-1H-吡咯嗪-5-甲醛 2,3-二氢-1H-吡呤-1,7-二羧酸 2,3-二氢-(6ci,7ci,8ci,9ci)-1H-吡咯里嗪-1-酮 2,3,5,7a-四氢-1H-吡咯烷 2,2-二氯-1-(3H-吡咯里嗪-5-基)乙酮 1H-吡咯里嗪-2(3H)-酮 1H-吡咯啉嗪-6-羧酸,2,3-二氢-5-甲基-,甲基酯 1H-吡咯啉嗪-5,7-二甲腈,6-氨基-2,3-二氢- 1-甲酰基-6,7-二氢-5H-吡咯里嗪 1-甲基-2,3-二氢-1H-吡咯里嗪 1-氧代-2,3-二氢-1H-吡咯里嗪-7-甲醛 1-氧代-1H-吡咯里嗪-2-甲酰氯